Pages that link to "Q27027835"
Jump to navigation
Jump to search
The following pages link to Small molecule compounds targeting the p53 pathway: are we finally making progress? (Q27027835):
Displaying 36 items.
- Chemical Variations on the p53 Reactivation Theme (Q26749008) (← links)
- The Growing Complexity of Cancer Cell Response to DNA-Damaging Agents: Caspase 3 Mediates Cell Death or Survival? (Q26749064) (← links)
- Apoptosis as anticancer mechanism: function and dysfunction of its modulators and targeted therapeutic strategies (Q26750639) (← links)
- Reactivating mutant p53 using small molecules as zinc metallochaperones: awakening a sleeping giant in cancer (Q26800059) (← links)
- Mutant p53 regulates ovarian cancer transformed phenotypes through autocrine matrix deposition. (Q27333756) (← links)
- The role of p53 in cancer drug resistance and targeted chemotherapy (Q28072553) (← links)
- Binding cavities and druggability of intrinsically disordered proteins (Q35571730) (← links)
- The beneficial effect of Zinc(II) on low-dose chemotherapeutic sensitivity involves p53 activation in wild-type p53-carrying colorectal cancer cells (Q35986990) (← links)
- Zn(II)-curc targets p53 in thyroid cancer cells (Q36094135) (← links)
- The cholesterol metabolite 27-hydroxycholesterol regulates p53 activity and increases cell proliferation via MDM2 in breast cancer cells (Q36766027) (← links)
- Allele-specific silencing of mutant p53 attenuates dominant-negative and gain-of-function activities (Q36905671) (← links)
- Genetic alteration profiling of patients with resected squamous cell lung carcinomas (Q37392781) (← links)
- Effect of the p53α gene on the chemosensitivity of the H1299 human lung adenocarcinoma cell line (Q38695489) (← links)
- 3-Arylidene-N-hydroxyoxindoles: A New Class of Compounds Endowed with Antitumor Activity (Q38764064) (← links)
- Aggregation and Prion-Like Properties of Misfolded Tumor Suppressors: Is Cancer a Prion Disease? (Q38934098) (← links)
- Exploiting the p53 Pathway for Therapy. (Q39134087) (← links)
- New Insight into microRNA Functions in Cancer: Oncogene-microRNA-Tumor Suppressor Gene Network. (Q39453653) (← links)
- Down regulation of Chk1 by p53 plays a role in synergistic induction of apoptosis by chemotherapeutics and inhibitors for Jak2 or BCR/ABL in hematopoietic cells. (Q39987364) (← links)
- Role of tumor suppressor p53 and micro-RNA interplay in multiple myeloma pathogenesis (Q44027685) (← links)
- RITA plus 3-MA overcomes chemoresistance of head and neck cancer cells via dual inhibition of autophagy and antioxidant systems (Q46356056) (← links)
- Small-molecule stabilization of the p53 - 14-3-3 protein-protein interaction. (Q47995141) (← links)
- (+)-Strebloside-Induced Cytotoxicity in Ovarian Cancer Cells Is Mediated through Cardiac Glycoside Signaling Networks. (Q48198204) (← links)
- Drug Repositioning in Glioblastoma: A Pathway Perspective. (Q52608766) (← links)
- The Relationship between TP53 Gene Status and Carboxylesterase 2 Expression in Human Colorectal Cancer. (Q52719672) (← links)
- Zinc Metallochaperones as Mutant p53 Reactivators: A New Paradigm in Cancer Therapeutics. (Q55471290) (← links)
- The Rational Discovery of a Tau Aggregation Inhibitor (Q56978719) (← links)
- Emerging ways to treat breast cancer: will promises be met? (Q57105553) (← links)
- Targeted Therapies in Type II Endometrial Cancers: Too Little, but Not Too Late (Q57169683) (← links)
- Literature-based automated discovery of tumor suppressor p53 phosphorylation and inhibition by NEK2 (Q57460087) (← links)
- IL-24 Promotes Apoptosis through cAMP-Dependent PKA Pathways in Human Breast Cancer Cells (Q59810229) (← links)
- Modulation of Disordered Proteins with a Focus on Neurodegenerative Diseases and Other Pathologies (Q64087496) (← links)
- Dynamic conformational flexibility and molecular interactions of intrinsically disordered proteins (Q89535892) (← links)
- Anti-cancer Potential of Captopril and Botulinum Toxin Type-A and Associated p53 Gene Apototic Stimulating Activity (Q90411769) (← links)
- p53 Isoforms in Cellular Senescence- and Ageing-Associated Biological and Physiological Functions (Q91645670) (← links)
- The Benefit of Reactivating p53 under MAPK Inhibition on the Efficacy of Radiotherapy in Melanoma (Q92372745) (← links)
- Pharmacological targeting of mutant p53 (Q92914764) (← links)